Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Planet Labs (PL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Planet Labs — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Planet Labs trades at $13.74 (market cap $5.52B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 5.6× Planet Labs's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Planet Labs pays none. Which is the better fit depends on your goals.
| GEHC | PL | |
|---|---|---|
Market Cap | $31.07B | $5.52B |
Volume | 3,443,020 | 10,123,547 |
Sector | Health | Industrials |
52-Week High | $88.16 | $51.40 |
52-Week Low | $59.48 | $11.16 |
Enterprise Value | $39.53B | $5.15B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 6 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Planet Labs (PL) trades at $15.16, down 5.01% on the day, reflecting ongoing bearish technical pressure despite recent satellite launches and government contract wins. The company shows revenue growth potential with $378 million projected for 2026, but faces significant profitability challenges with a -95.13% net income margin and negative ROE of -71.97%. Analyst sentiment remains positive with 13 buy ratings and a $32.50 consensus price target, though technical indicators signal bearish momentum.
The stock presents a high-risk opportunity with substantial upside potential if execution improves, but current financial performance and bearish technicals warrant caution. Key catalysts include defense contract execution and satellite deployment success, while risks include persistent losses, competitive pressure from SpaceX, and valuation concerns at current P/S of 13.35.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Planet Labs
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →
